Active, not recruitingPHASE2, PHASE3NCT06174402

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis

Studying Primary biliary cholangitis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Han Ying
Intervention: Fenofibrate(drug)
Enrollment: 184 target
Eligibility: 18-75 years · All sexes
Timeline: 2023 – 2026

Study locations (10)

The second hospital of Lanzhou University, Lanzhou, Gansu, China
Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China
Jiangsu Province Hospital, Nanjing, Jiangsu, China
Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China
Nanjing Second Hospital, Nanjing, Jiangsu, China
Shengjing Hospital Affiliated to China Medical University, Shenyang, Liaoning, China
Xijing Hospital, Xi'an, Shaanxi, China
Yan'an University Affiliated Hospital, Yan’an, Shanxxi, China
The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
Peking Union Medical College Hospital, Beijing, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06174402 on ClinicalTrials.gov

Other trials for Primary biliary cholangitis

Additional recruiting or active studies for the same condition.

See all trials for Primary biliary cholangitis →

← Back to all trials